Clinical trials: Benign Hyperplasia of Prostate
Lower Urinary Tract Symptoms, Benign Prostatic Hyperplasia
Evaluation of the Safety, Tolerability, and Efficacy of the Omega System for the Treatment of LUTS Due to BPH
This is a prospective, two-stage, multi-center, pilot clinical study to evaluate the safety/tolerability/efficacy of the Omega System device.
- Trial name
- Omega (NCT05757687)
- Testing
- Omega device
- Where
- 5 sites in Georgia
- Volunteers
- 11 people
- Sponsor
- ProArc Medical
Bladder Cancer, Benign Prostate Hyperplasia
The Effect of Preemptive Analgesia On The Comfort Of Patient and Doctor, in Cystoscopy
The study was designed as a prospective, randomized double-blind placebo controlled trial. According to power analysis in regards of previous studies in the literature with diclofenac sodium, using a total of 144 patients are…
- Conditions
- Bladder Cancer, Benign Prostate Hyperplasia, Hematuria, Pain
- Trial name
- NCT03831321
- Testing
- Diclofenac Sodium, Cystoscopy, Lubricant Gel
- Where
- Turkey (Türkiye)
- Volunteers
- 144 people
- Sponsor
- Taha Uçar
Benign Prostatic Hyperplasia
Embozene® Microspheres for Prostatic Arterial Embolization in Patients With Symptomatic Benign Prostatic Hyperplasia
The purpose of this observational study is to evaluate the prostatic arterial embolization (PAE) with Embozene® Microspheres (Boston Scientific) in sphere sizes of 250 µm for the treatment of symptomatic benign prostatic…
- Trial name
- EmboProstate (NCT02206243)
- Testing
- Embozene Microspheres
- Where
- Germany
- Volunteers
- 300 people
- Sponsor
- Jena University Hospital
Prostate Hypertrophy, Holmium Laser
Holmium Laser Versus Thulium Laser Versus Bipolar Enucleation of the Prostate.
Because of the diversity of the studies and deficiency of those comparing various techniques of EEP for treatment of LUTs secondary to BPO in patients with large sized prostate, we aim in this study at testing the non-inferiority…
- Conditions
- Prostate Hypertrophy, Holmium Laser, Thulium Laser, Bipolar Diathermy
- Trial name
- NCT03916536
- Testing
- Holmium Laser, Thulium Laser, Bipolar diathermy
- Where
- Egypt
- Volunteers
- 155 people
- Sponsor
- Mansoura University
Nocturia, Prostatic Hyperplasia
A Study of Silodosin 8 mg Daily for the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia
Silodosin is compared to placebo to determine if it is safe and effective for the treatment of nighttime urination (nocturia) in men with BPH
- Trial name
- NCT00793819
- Testing
- silodosin
- Where
- 27 sites in United States
- Volunteers
- 215 people
- Sponsor
- Watson Pharmaceuticals
PSA Changes After TURP
Serum Prostatic Specific Antigen Changes After Bipolar and Monopolar TURP
To use PSA levels after bipolar and monopolar transurethral resection of the benign prostatic hyperplasia as an indicator of the quality of resection .
- Trial name
- NCT05533047
- Testing
- TURP
- Volunteers
- 2 people
- Sponsor
- Assiut University
BPH (Benign Prostatic Hyperplasia), HoLEP (Holmium Laser Enucleation of Prostate)
A Study of the Beacon Platform for Holmium Laser Enucleation of the Prostate (HoLEP)
This single-arm study aims to evaluate the Beacon Platform, an advancement in urological surgery. The study will assess its intraoperative and postoperative outcomes.
- Trial name
- NCT07741656
- Testing
- Beacon Platform
- Where
- 5 sites in Bulgaria, Chile and 1 more
- Volunteers
- 50 people
- Sponsor
- Andromeda Surgical
Benign Prostatic Hyperplasia (BPH)
Urodynamic Evaluation of Disobstrucitve Power of Aquablation VS Laser Techniques
in the last decade, lots of attemps have been done to identify new technologies able to reply the efficacy of gold standard technique for treating BPH, but with a better safety profile.
- Trial name
- NCT03846700
- Testing
- aquablation, holep, pvp
- Where
- Italy
- Volunteers
- 40 people
- Sponsor
- University of Bari
Benign Prostatic Hyperplasia
Safety and Effectiveness of the Optilume® BPH Catheter System in a Post-Market Study
The goal of this clinical trial is to verify the continued safety and effectiveness for the Optilume BPH Catheter System.
- Trial name
- PEAK (NCT06312722)
- Testing
- Optilume® BPH Catheter System
- Where
- 7 sites in United States
- Volunteers
- 92 people
- Sponsor
- Urotronic Inc.
BPH (Benign Prostatic Hyperplasia), Lower Urinary Tract Symptoms
RT-310 Dose Escalation BPH Study
RT-310, a novel implant, is intended to minimally invasive treat locally the prostate gland for the management of prostate disease, while minimizing side-effects.
- Trial name
- NCT06136819
- Testing
- RT-310
- Where
- 4 sites in Australia, New Zealand
- Volunteers
- 20 people
- Sponsor
- Resurge Therapeutics Inc.
Prostatic Hyperplasia, Lower Urinary Tract Symptoms
Benign Prostatic Hyperplasia (BPH) Mobile Application Pilot Study
This study assesses the feasibility, and acceptability of a (mobile) application for men presenting at their physician's office with LUTS/BPH; starting with medical therapy and naïve for treatment.
- Trial name
- NCT03228485
- Testing
- MyBPH Care mobile app
- Where
- 5 sites in Greece, Italy and 3 more
- Volunteers
- 200 people
- Sponsor
- Société Internationale d'Urologie
Benign Prostatic Hyperplasia, Lower Urinary Tract Symptoms (LUTS) in Men With Benign Prostatic Hyperplasia (BPH)
Selective Median Lobe Surgery Outcomes Study
This prospective multicenter observational cohort study will evaluate clinical outcomes after selective median lobe transurethral surgery for benign prostatic obstruction.
- Conditions
- Benign Prostatic Hyperplasia, Lower Urinary Tract Symptoms (LUTS) in Men With Benign Prostatic Hyperplasia (BPH), Benign Prostatic Obstruction, Urinary Retention
- Trial name
- UNVEIL-BPO (NCT07699718)
- Testing
- Selective Median Lobe TURP, Selective Median Lobe HoLEP/AEEP
- Where
- 2 sites in Turkey (Türkiye)
- Volunteers
- 420 people
- Sponsor
- Necmettin Erbakan University
Benign Prostatic Hyperplasia
Perioperative Parameter and Treatment Outcomes of Surgical Treatment for Benign Prostate Hyperplasia in Hong Kong
This is a prospective data registry to assess the treatment outcomes and complications of different treatment approaches in our hospital clusters.
- Trial name
- NCT05292235
- Where
- 3 sites in Hong Kong
- Volunteers
- 2,000 people
- Sponsor
- Chinese University of Hong Kong
BPH
Efficacy of Prunus Domestica Extract in BPH
Benign prostatic hyperplasia (BPH) is a nonmalignant enlargement of the prostate Prunus domestica bark contains three groups of active constituents: phytosterols (including beta-sitosterol), pentacyclic triterpenoids (including…
- Trial name
- NCT02702947
- Testing
- Prunus domestica extract
- Where
- India
- Volunteers
- 160 people, healthy volunteers welcome
- Sponsor
- Chemical Resources
Benign Prostatic Hyperplasia, Lower Urinary Tract Symptoms
Effect of Different Dosing Regimens of Tadalafil or Tamsulosin Combined With 5α-Reductase Inhibitors on Urinary and Sexual Outcomes in Benign Prostatic Hyperplasia
Benign prostatic hyperplasia (BPH) is a common condition among aging men that causes lower urinary tract symptoms (LUTS) and may negatively affect sexual function.
- Conditions
- Benign Prostatic Hyperplasia, Lower Urinary Tract Symptoms, Erectile Dysfunction
- Trial name
- DTT-BPH (NCT07715448)
- Testing
- Tamsulosin, Tadalafil, 5-Alpha Reductase Inhibitor
- Where
- Egypt
- Volunteers
- 240 people
- Sponsor
- Beni-Suef University
TURP(Transurethral Resection of Prostate), BPH (Benign Prostatic Hyperplasia)
Corkscrew Technique: A Novel Modification in Transurethral Resection of Large Prostate (60-100 g) Optimizing Resection Efficacy and Safety: A Double-blind Randomized Controlled Trial
Transurethral resection of the prostate (TURP) is still the gold standard for surgical management of enlarged prostate. However, many techniques and minimally invasive procedures are now in the comparative track with Bipolar…
- Conditions
- TURP(Transurethral Resection of Prostate), BPH (Benign Prostatic Hyperplasia), Prostate
- Trial name
- NCT06901115
- Testing
- Nesbit technique, Corkscrew technique
- Where
- Egypt
- Volunteers
- 90 people
- Sponsor
- Menoufia University
BPH (Benign Prostatic Hyperplasia)
A Single-center, Single-arm Study to Evaluate the Safety and Efficacy of Ultra-minimally Invasive Prostate Dilation in Treating Patients With Significant Obstructive Symptoms Caused by Benign Prostatic Hyperplasia
This single-center, single-arm, prospective clinical study aims to preliminarily evaluate the safety and effectiveness of ultra-minimally invasive prostatic dilation using a prostate dilation catheter under real-time transrectal…
- Trial name
- UMPD-BPH (NCT07583706)
- Testing
- Prostate Dilation Catheter
- Where
- China
- Volunteers
- 5 people
- Sponsor
- Qing Yuan
Benign Prostatic Hyperplasia
Clinical Trial of Safety and Efficacy of Afalaza in Patients With Symptoms of Benign Prostatic Hyperplasia and Risk of Progression
The purpose of this study is: To assess safety of Afalaza drug within 12 months in patients with symptoms of benign prostatic hyperplasia (BPH) and risk of progression.
- Trial name
- NCT01716104
- Testing
- Afalaza
- Where
- 16 sites in Russia, Ukraine
- Volunteers
- 260 people
- Sponsor
- Materia Medica Holding
BPH, Erectile Dysfunction
Uroxatral in Men With Benign Prostate Hypertrophy (BPH) and Erectile Dysfunction (ED)
Uroxatral (alfuzosin) may not only help BPH symptoms but may also improve sexual function in males with BPH and ED.
- Trial name
- NCT00256399
- Testing
- Alfuzosin 10 mg
- Where
- United States
- Volunteers
- 6 people, healthy volunteers welcome
- Sponsor
- University Hospitals Cleveland Medical Center
Neoplasms, Prostate, Prostate Cancer
Korean Practice Patterns for Screening PCA(Prostate Cancer)
This is to investigate Korean urologist's practice patterns for screening prostate cancer according to PSA level.
- Conditions
- Neoplasms, Prostate, Prostate Cancer, Benign Prostatic Hyperplasia
- Trial name
- RESPECT (NCT01371513)
- Testing
- continuous screening
- Where
- South Korea
- Volunteers
- 1 people
- Sponsor
- GlaxoSmithKline